MEDIPLAST AS

3044 DRAMMEN

Finances

Share Ownership

Return on Equity

62,32 %

Current Ratio

1,83

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	111 767 000	117 913 000	187 445 000	86 412 000
Net Income	9 749 000	9 362 000	22 045 000	1 243 000
Total Assets	34 148 000	34 034 000	43 376 000	25 893 000
Total Equity	15 643 000	18 894 000	9 532 000	5 488 000

Income (NOK)	2022	2021	2020	2019
Revenue	111 767 000	117 913 000	187 445 000	86 412 000
Expenditure	99 744 000	105 591 000	159 337 000	84 753 000
Operating Profit	12 023 000	12 322 000	28 109 000	1 659 000
Financial Income	175 000	3 000	261 000	108 000
Financial Costs	5 000	4 000	99 000	133 000
Financial Balance	170 000	−1 000	162 000	−25 000
Earnings Before Tax	12 193 000	12 321 000	28 271 000	1 634 000
Tax	2 445 000	2 959 000	6 226 000	391 000
Net Income	9 749 000	9 362 000	22 045 000	1 243 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	320 000	200 000	715 000	1 035 000
Total Current Assets	33 827 000	33 834 000	42 661 000	24 858 000
Total Assets	34 148 000	34 034 000	43 376 000	25 893 000
Total Retained Equity	14 293 000	17 544 000	8 182 000	4 138 000
Total Equity	15 643 000	18 894 000	9 532 000	5 488 000
Total Long-Term Debt	0	0	0	13 000 000
Total Current Debt	18 505 000	15 140 000	33 844 000	7 405 000
Total Equity and Debt	34 148 000	34 034 000	43 376 000	25 893 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	111 767 000	117 617 000	187 380 000	83 103 000
Other Income	0	296 000	66 000	3 309 000
Revenue	111 767 000	117 913 000	187 445 000	86 412 000
Cost of Goods Sold	76 543 000	86 383 000	143 475 000	69 812 000
Salary Costs	9 009 000	8 116 000	7 077 000	6 654 000
Depreciation	160 000	368 000	378 000	293 000
Impairment	0	0	0	0
Expenditure	99 744 000	105 591 000	159 337 000	84 753 000
Operating Profit	12 023 000	12 322 000	28 109 000	1 659 000
Financial Income	175 000	3 000	261 000	108 000
Financial Costs	5 000	4 000	99 000	133 000
Financial Balance	170 000	−1 000	162 000	−25 000
Dividends	0	0	18 000 000	1 000 000
Net Income	9 749 000	9 362 000	22 045 000	1 243 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	281 000	98 000	588 000	843 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	39 000	29 000	127 000	192 000
Total Tangible Assets	39 000	102 000	127 000	192 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	320 000	200 000	715 000	1 035 000
Stock	2 514 000	2 003 000	2 639 000	1 993 000
Total Investments	0	0	0	0
Cash, Bank	17 157 000	17 642 000	11 577 000	5 846 000
Total Current Assets	33 827 000	33 834 000	42 661 000	24 858 000
Total Assets	34 148 000	34 034 000	43 376 000	25 893 000
Total Equity	15 643 000	18 894 000	9 532 000	5 488 000
Short-Term Group Debt	7 500 000	3 750 000	0	0
Total Long-Term Debt	0	0	0	13 000 000
Creditors	375 000	1 079 000	1 861 000	103 000
Unpaid Taxes	5 633 000	5 486 000	4 743 000	4 729 000
Dividends	0	0	18 000 000	1 000 000
Other Current Debt	2 271 000	2 062 000	2 975 000	1 039 000
Total Current Debt	18 505 000	15 140 000	33 844 000	7 405 000
Total Equity and Debt	34 148 000	34 034 000	43 376 000	25 893 000

Financial indicators	2022	2021	2020	2019
Return on Equity	62,32 %	49,55 %	231,27 %	22,65 %
Debt-to-Equity Ratio	0	0	0	2,37
Operating Profit Margin	10,76 %	10,45 %	15 %	1,92 %
Current Ratio	1,83	2,23	1,26	3,36
Quick Ratio	2,12	2,58	1,37	4,59
Equity Ratio	0,46	0,56	0,22	0,21
Gross Profit Margin	31,52 %	26,74 %	23,46 %	19,21 %